Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Medical Device Company Baxter Acquires Tel Aviv-Headquartered Cheetah Medical for $190 Million
Error: Contact form not found.
by Adi Pick / CTech
A doctor performing a botox injection. Photo: Dr. Braun via Wikicommons.
CTech – New York-listed medical device company Baxter International has entered an agreement to acquire Boston and Tel Aviv-headquartered Cheetah Medical for $190 million in cash, with potential for an additional $40 million based on certain milestones, the former announced Tuesday.
The acquisition is expected to close in the fourth quarter of 2019, subject to customary closing conditions.
Founded in 2000, Cheetah Medical develops and provides non-invasive fluid management monitoring systems for use in critical care, operating rooms, and emergency rooms. Cheetah Medical’s fluid management systems are currently in use in 400 hospitals throughout the US and in 30 countries worldwide, according to company statements.
The company employs a team of approximately 120 employees, according to LinkedIn, in its Tel Aviv research and development center, and in offices in Boston, Vancouver, Washington, and the UK. Prior to the acquisition, Cheetah Medical had raised $117 million, according to Pitchbook data.
